Many considerations in selecting bioproduction culture media

BioProcess International

Volumn 7, Issue 1, 2009, Pages 44-51

  Decaria, Paula ^a   Smith, Alaine ^a   Whitford, William ^a  

^a Thermo Fisher Scientific   (United States)

Author keywords

Cell culture; Optimization; Process control; Scale up; Serum free media; Single use technologies

Indexed keywords

APOPTOSIS; BIOTECHNOLOGY; CELL CULTURE; CULTURE MEDIUM; PROCESS CONTROL; REVIEW;

EID: 77953469156     PISSN: 15426319     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Review

References (21)

1. Jerums M, Yang X. Optimization of Cell Culture Media. BioProcess Int. 3 (6), 2005: S38-S44.
2. Broedel Jr. SE, Papciak SM. The Case for Serum-Free Media. BioProcess Int. 1(2) 2003: 56-58.
3. Whitford WG. Chapter 5: Large-Scale Exogenous Protein Production in Higher Animal Cells. The GMO Handbook: Genetically Modified Animals, Microbes, and Plants in Biotechnology. Parekh SR, Ed. Humana Press: 2004.
4. Wong DCF, et al. Transcriptional Profiling of Apoptotic Pathways in Batch and Fed-Batch CHO Cell Cultures. Biotechnol. Bioeng. 94(2) 2006: 373-382.
5. Barnes LM, Bentley CM, Dickson AJ. Stability of Protein Production from Recombinant Mammalian Cells. Biotechnol. Bioeng. 81(6) 2003: 631-639.
6. Butler M. Animal Cell Cultures: Recent Achievements and Perspectives in the Production of Biopharmaceuticals. Appl. Microbiol. Biotechnol. 68, 2005: 283-291.
7. Serrato JA, et al. Differences in the Glycosylation of a Monoclonal Antibody Produced By Hybridomas Cultured in Serum-Supplemented, Serum-Free, or Chemically Defined Media. Biotechnol. Appl. Biochem. 47(2) 2007: 113-124.
8. Fahnertt, B. Chapter 3: Folding-Promoting Agents in Recombinant Protein Production. Recombinant Gene Expression: Reviews and Protocols. Vol 267. Balbás P, Lorence A, Eds. Humana Press, 2008: 53-74.
9. Even MS, Sandusky CB, Barnard ND. Serum-Free Hybridoma Culture: Ethical, Scientific and Safety Considerations. Trends Biotechnol. 24(3) 2006: 105-108.
10. Kondepati VR, Heise HM. The Potential of Mid- and Near-Infrared Spectroscopy for Reliable Monitoring of Bioprocesses. Curr. Trends Biotechnol. Pharmacy 2(1) 2008: 117-132.
11. Sitton G, Srienc F. Mammalian Cell Culture Scale-Up and Fed-Batch Control Using Automated Flow Cytometry. J. Biotechnol. 135(2) 2008: 174-180.
12. Whitford W, Julien C. Appendix 1: Designing for Process Robustness. BioProcess Int. 6(3) 2008: S60-S62.
13. Carlini P, et al. Purification and Characterization of Alpha-Fetoprotein from the Human Hepatoblastoma HepG2 Cell Line in Serum-Free Medium. Biometals 20, 2007: 869-878.
14. Altimirano C, et al. Strategies for Fed-Batch Cultivation of t-PA Producing CHO Cells: Substitution of Glucose and Glutamine and Rational Design of Culture Medium. J. Biotechnol. 110, 2004: 171-179.
15. Whitford W. Chapter 3: Supplementation of Animal Cell Culture Media. BioProcess Int. 3(6) 2005: S28-S36.
16. Montgomery SA, Jackewitz A. The Genesis of New Production Tools for Biotechnology Manufacturers or "What Can Be Done to Improve My Process?" BioProcess Int. 6(9) 2008: 44-50.
17. Gonzalez Hernandez Y, Fischer RW. Serum-Free Culturing of Mammalian Cells: Adaptation to and Cryopreservation in Fully Defined Media. ALTEX 24(2) 2007: 110-116.
18. Okonkowski J, et al. Cholesterol Delivery to NS0 Cells: Challenges and Solutions in Disposable Linear Low-Density Polyethylene-Based Bioreactors. J. Biosci. Bioeng. 103(1) 2007: 50-59.
19. Coco-Martin JM. Mammalian Expression of Therapeutic Proteins. BioProcess Int. 2(10) 2004: 32-40.
20. FiberCell Systems Inc.: Frederick, MD; www.fibercellsystems.com.
21. Kuchenbecker M, et al. Establishment of Recombinant CHO Cell Lines Under Serum-Free Conditions. Cell Technology for Cell Products. Smith R, Ed. Springer: The Netherlands, 2007: 57-61.